艾可萨乙烯 (VASCEPA) 是一种
Sean M Cruess1, Joseph Xavier Callahan2, Isabella Raso2
1Department of Biology, College of the Holy Cross, Worcester MA, USA.
伊科萨乙烯可能有助于解决长期的COVID症状. 这种欧米茄三脂肪酸衍生物在两项案例研究中显示出缓解COVID-19感染后持久后病毒综合征的前景.
科学领域:
- 免疫学 免疫学 免疫学
- 病毒学 病毒学
- 药理学 药理学是指药理学的学科.
背景情况:
- 长期COVID是一种多器官后病毒综合征,在感染后持续存在.
- 目前对于长期的COVID没有确定的治疗方法.
- 持续的炎症与长期的COVID病原发生有关.
研究的目的:
- 评估IcosapentEthyl在治疗长期COVID中的有效性.
- 探索Icosapent Ethyl作为治疗后病毒综合征的免疫调节疗法的潜力.
主要方法:
- 分析了两个成人病例研究.
- 用Icosapent Ethyl治疗,这是一个omega-3脂肪酸衍生物.
- 专注于经历持续长期COVID症状的患者.
主要成果:
- 案例研究中的两个人都经历了症状的消失.
- 伊科萨乙烯治疗与缓解长期COVID症状有关.
结论:
- 伊科萨乙烯可能是长期COVID症状缓解的决定性因素.
- 需要进一步的临床研究来确认Icosapent Ethyl对长期COVID的疗效.
更多相关视频
09:43In vivo Near Infrared Fluorescence NIRF Intravascular Molecular Imaging of Inflammatory Plaque, a Multimodal Approach to Imaging of Atherosclerosis
Published on: August 4, 2011
08:18Self-Nanoemulsification of Healthy Oils to Enhance the Solubility of Lipophilic Drugs
Published on: July 27, 2022
相关概念视频
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Esters to Carboxylic Acids: Saponification
The reaction requires a base in stoichiometric amounts, which participates in the reaction and is not regenerated later. So, the base acts as a...
Coronary Artery Disease V: Interprofessional Care
Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors
